MedPath

One Week Aligner Evaluation

Completed
Conditions
Malocclusion
Interventions
Device: Invisalign
Registration Number
NCT02603289
Lead Sponsor
Align Technology, Inc.
Brief Summary

The purpose of this study is to demonstrate that changing aligners weekly provides similar results to changing aligners every two weeks.

Detailed Description

The Invisalignยฎ System consists of a series of clear plastic aligners that are intended to replace conventional wire and bracket technology for many orthodontic cases. Each custom manufactured aligner exerts gentle, continuous forces to move teeth incrementally from their original state to a final, treated state. The aligners are designed to optimally move each tooth at a speed that follows physiologic principles. The purpose of this study is to demonstrate that changing aligners weekly provides similar results to changing aligners every two weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
287
Inclusion Criteria
  • Subject must have fully erupted dentition except for 2nd and 3rd molars
  • For Teen treatment group, subjects ages <17 years of age
  • For Adult treatment group, subjects โ‰ฅ17 years of age
Exclusion Criteria
  • Subject has undergone any accelerated orthodontic treatment prior to or during treatment as part of this study
  • Subject with active caries
  • Subject with periodontal disease
  • Subject with TMD symptoms
  • Subject has known allergy to latex or plastic
  • Subjects who are pregnant or will become pregnant during treatment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Adult with Primer AlignersInvisalign17 years of age or older This group will get Primer Aligners
AdultInvisalign17 years of age or older
TeenInvisalign\< 17 years of age
Primary Outcome Measures
NameTimeMethod
Planned to Final Tooth PositionThrough study completion, an average of 2 years

Test vs Historical Control Group

Secondary Outcome Measures
NameTimeMethod
Treatment timeThrough study completion, an average of 2 years

Length of treatment

Subject Quality of LifeThrough study completion, an average of 2 years

Assessment of QoL

Trial Locations

Locations (24)

Dr. Sean Holliday

๐Ÿ‡บ๐Ÿ‡ธ

Pearl City, Hawaii, United States

Dr. Mark Perelmuter

๐Ÿ‡บ๐Ÿ‡ธ

Louisville, Kentucky, United States

Dr. Ryan Caudill

๐Ÿ‡บ๐Ÿ‡ธ

Merritt Island, Florida, United States

Dr. Zvi Kennet

๐Ÿ‡บ๐Ÿ‡ธ

Macomb, Michigan, United States

Dr. Anil Idiculla

๐Ÿ‡บ๐Ÿ‡ธ

Lone Tree, Colorado, United States

Dr. William Gierie

๐Ÿ‡บ๐Ÿ‡ธ

Wilmington, North Carolina, United States

Dr. Clark Colville

๐Ÿ‡บ๐Ÿ‡ธ

Seguin, Texas, United States

Dr. Thomas Marcel

๐Ÿ‡บ๐Ÿ‡ธ

Livermore, California, United States

Dr. David Chenin

๐Ÿ‡บ๐Ÿ‡ธ

Henderson, Nevada, United States

Dr. Carlyn Phucas

๐Ÿ‡บ๐Ÿ‡ธ

Marlton, New Jersey, United States

Dr. Bart Iwasiuk

๐Ÿ‡จ๐Ÿ‡ฆ

Brampton, Ontario, Canada

Dr. Brian Amy

๐Ÿ‡บ๐Ÿ‡ธ

Oklahoma City, Oklahoma, United States

Dr. Robery Van den Berg

๐Ÿ‡บ๐Ÿ‡ธ

San Ramon, California, United States

Dr. Mary Cooke

๐Ÿ‡บ๐Ÿ‡ธ

Napa, California, United States

Align Technology, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

San Jose, California, United States

Dr. Jeff Mastroianni

๐Ÿ‡บ๐Ÿ‡ธ

Glen Carbon, Illinois, United States

Dr. James Crouse

๐Ÿ‡บ๐Ÿ‡ธ

Salisbury, Maryland, United States

Dr. Thomas Everett

๐Ÿ‡บ๐Ÿ‡ธ

Burnsville, Minnesota, United States

Dr. Justin Wild

๐Ÿ‡บ๐Ÿ‡ธ

Eden Prairie, Minnesota, United States

Dr. William Kottemann

๐Ÿ‡บ๐Ÿ‡ธ

Maple Grove, Minnesota, United States

Dr. Regina Blevins

๐Ÿ‡บ๐Ÿ‡ธ

Inver Grove Heights, Minnesota, United States

Dr. Bella Shen Garnett

๐Ÿ‡บ๐Ÿ‡ธ

San Francisco, California, United States

Dr. Vincent D'Ascoli

๐Ÿ‡บ๐Ÿ‡ธ

Carson City, Nevada, United States

Dr. David Paquette

๐Ÿ‡บ๐Ÿ‡ธ

Mooresville, North Carolina, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath